Literature DB >> 12611376

Seronegative spondyloarthropathy of familial Mediterranean fever.

Nurgül Arinci Incel1, Meryem Saraçoğlu, H Rana Erdem.   

Abstract

Familial Mediterranean fever (FMF) is characterized by an autosomal inheritance pattern, Mediterranean ancestry, and history of recurrent fever. We present a 30-year-old Turkish man with FMF and accompanying seronegative spondyloarthropathy. His diagnose depended on the clinical course of his disease: recurrent fever accompanied by abdominal pain attacks together with a positive family history and his ethnic origin and sacroiliitis. We review the common manifestations of FMF and remind physicians that sacroiliac joint involvement must be kept in mind in presence of articular symptoms in a FMF patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611376     DOI: 10.1007/s00296-002-0239-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  9 in total

1.  M694V mutation may have a role in susceptibility to ankylosing spondylitis.

Authors:  Servet Akar; Merih Birlik; Ismail Sari; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2009-01-17       Impact factor: 2.631

2.  Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.

Authors:  Birol Balaban; Evren Yasar; Ahmet Ozgul; Kemal Dincer; Tunc Alp Kalyon
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

Review 3.  Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Işik Keleş; Gülümser Aydin; Aliye Tosun; Elem Inal; Hatice Keleş; Sevim Orkun
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

4.  Familial Mediterranean fever responds well to infliximab: single case experience.

Authors:  Salih Ozgocmen; Levent Ozçakar; Ozge Ardicoglu; Ercan Kocakoc; Arzu Kaya; Adem Kiris
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

5.  Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.

Authors:  S Erten; S F Erten; A Altunoglu
Journal:  Rheumatol Int       Date:  2011-03-23       Impact factor: 2.631

6.  Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up?

Authors:  Mustafa Yildiz; S Ercan Tunc; Mehmet Sahin; Berna Okudan; Osman Aydin; Harun Suslu; Meltem Ozbek
Journal:  Rheumatol Int       Date:  2005-02-03       Impact factor: 2.631

7.  The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study.

Authors:  Muhammet Cinar; Ayhan Dinc; Ismail Simsek; Hakan Erdem; Bayram Koc; Salih Pay; Yusuf Tunca; Selim Kilic; Davud Gul
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

8.  Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever.

Authors:  Mehmet D Demirag; Mehmet A Ozturk; Berna Goker; Seminur Haznedaroglu
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

9.  Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy.

Authors:  Hatice Bodur; Umit Seçkin; Filiz Eser; Gülüşan Ergül; Selda Seçkin
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.